HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)
![Western blot - HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)](https://www.abcam.com/ps/products/201/ab201995/Images/ab201995-314997-anti-o-linked-n-acetylglucosamine-antibody-rl2-hrp-western-blot.jpg "Western blot - HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)")
Key features and details
- HRP Mouse monoclonal [RL2] to O-Linked N-Acetylglucosamine
- Suitable for: IHC-P, WB
- Reacts with: Human
- Conjugation: HRP
- Isotype: IgG1
Overview
-
Product name
HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2]
See all O-Linked N-Acetylglucosamine primary antibodies -
Description
HRP Mouse monoclonal [RL2] to O-Linked N-Acetylglucosamine -
Host species
Mouse -
Conjugation
HRP -
Tested applications
Suitable for: IHC-P, WBmore details -
Species reactivity
Reacts with: Human -
Positive control
- IHC-P: Normal human colon tissue. WB: Jurkat treated with 0 uM PugNAc and Jurkat treated with 4 mM glucosamine and 50 uM PugNAc (3 hours).
-
General notes
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. Store In the Dark. -
Storage buffer
pH: 7.40
Preservative: 0.1% 10% Proclin 300 Solution
Constituents: PBS, 30% Glycerol, 1% BSA -
Concentration information loading... -
Purity
IgG fraction -
Clonality
Monoclonal -
Clone number
RL2 -
Isotype
IgG1 -
Research areas
Associated products
-
Alternative Versions
-
Related Products
Applications
Our Abpromise guarantee covers the use of ab201995 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC-P | 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. | |
| WB | 1/1000. |
Target
-
Relevance
Many cellular proteins, including nuclear pore, oncogene, cytoskeletal, heat shock, viral and transcription regulatory proteins contain single O-linked N-acetylglucosamine (O-GlcNAc) residues attached to serine or threonine residues. It has been observed that O-GlcNAc glycosylated proteins tend to be under phosphorylated relative to unglycosylated proteins and that O-GlcNAc bearing proteins tend to be found in multimeric complexes. This has led to the suggestion that O-GlcNAc glycosylation may obscure phosphorylation sites and acts as a signaling mechanism or mediator of signaling.
Images
-
Western blot - HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)All lanes : HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995) at 1/1000 dilution
Lane 1 : Jurkat treated with 0 uM PugNAc
Lane 2 : Jurkat treated with 4 mM glucosamine and 50 uM PugNAc (3 hours)
Lysates/proteins at 20 µg per lane.
Performed under reducing conditions.
Observed band size: 100,65 kDa why is the actual band size different from the predicted?
Exposure time: 2 minutesThis blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab201995 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
-
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)](https://www.abcam.com/ps/products/201/ab201995/Images/ab201995-248594-anti-o-linked-n-acetylglucosamine-antibody-rl2-hrp-immunohistochemistry.jpg)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab201995)IHC image of O-linked N-Acetylglucosamine staining in a section of formalin-fixed paraffin-embedded normal human colon tissue*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab201995, 1/100 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
Protocols
References (0)
ab201995 has not yet been referenced specifically in any publications.
